The global pandemic of SARS-Cov-2 (COVID19) is presenting extremely challenging times for all those working to care for children with cancer and their families around the world. Many of you have had to change the way you provide care and contribute your staff and personal efforts towards other services in your hospitals. Every service is having to plan and re-plan as local situations are evolving rapidly.
Hi, my name is Jess Morgan –I’m a member of the SIOP YI-NET board and an NIHR Clinical Lecturer in the UK (I work part time as a clinician, and part time as a researcher). This week I’m blogging about what makes a SIOP Young Investigator, and also sharing a little bit about the YI […]
I am a MD, with a PhD is cancer genetics and I was wanting to tell you a little about some of my views on why you should, or should not do a PhD. This is especially relevant for YIs with a medical background, whose core training is already so long and intense. Still, you might be considering this PhD option and I hope this post can be of guidance to you.
Hi everyone, I am Austin Brown, a molecular epidemiologist and Assistant Professor of Pediatrics at Baylor College of Medicine in Houston, Texas (USA). Over the past several years, I have been fortunate to collaborate with the . I am pleased to announce the CCSS has released applications for the 2019 CCSS Career Development Award. The […]
Hi, my name is Yoshiko Nakano, and I am a pediatric oncologist in Japan. Shinsuke Hirabayashi and I will join the YI committee for the upcoming 50th SIOP Congress in Kyoto. Today, we would like to write about some aspects of the current status of pediatric hematology/oncology in Japan.
Hi everyone. My name is Sarah, I am a French pediatric oncology fellow and also a new member of the YI Blog committee. Today I would like to share my thoughts with you, about how I try and train my English and why I think it is a major part of being an active YI, if English is not your mother tongue.
Hi Everyone! My name is Gemma, I’m a SIOP YI Board member. Today I am posting on behalf of Dr Guillaume Bergthold, who shares his experiences of his Fellowship in Industry with Roche.